M343-1089 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide

M343-1089 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide
M343-1089 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M343-1089
N-(2H-1,3-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M343-1089

Molecular Formula

C23H26N4O6S (C23 H26 N4 O6 S)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-[2-oxo-3-(propan-2-yl)-6-(pyrrolidine-1-sulfonyl)-23-dihydro-1H-13-benzodiazol-1-yl]acetamide

SMILES

CC(C)N(c(ccc(S(N1CCCC1)(=O)=O)c1)c1N1CC(Nc(cc2)cc3c2OCO3)=O)C1=O

InChI

InChI=1S/C23H26N4O6S/c1-15(2)27-18-7-6-17(34(30,31)25-9-3-4-10-25)12-19(18)26(23(27)29)13-22(28)24-16-5-8-20-21(11-16)33-14-32-20/h5-8,11-12,15H,3-4,9-10,13-14H2,1-2H3,(H,24,28)

InChI Key

UFLHTDSSXLTKJU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27537615

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.55

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.436

Distribution Coefficient, logD

3.436

Water Solubility, LogSw

-3.97

Polar Surface Area

90.183

Acid Dissociation Constant (pKa)

11.54

Base Dissociation Constant (pKb)

4.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

M343-1089 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with M343-1089 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M343-1089?
Check Price and Availability of M343-1089, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M343-1089 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M343-1089
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M343-1089
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M343-1089 available by request